4a6v

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: '''Unreleased structure''' The entry 4a6v is ON HOLD Authors: Huguet, F., Melet, A., AlvesdeSousa, R., Lieutaud, A., Chevalier, J., Deschamps, P., Tomas, A., Leulliot, N., Pages, J.M., ...)
Current revision (11:20, 20 December 2023) (edit) (undo)
 
(7 intermediate revisions not shown.)
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 4a6v is ON HOLD
+
==X-ray structures of oxazole hydroxamate EcMetAp-Mn complexes==
 +
<StructureSection load='4a6v' size='340' side='right'caption='[[4a6v]], [[Resolution|resolution]] 1.46&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[4a6v]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli_BL21(DE3) Escherichia coli BL21(DE3)]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4A6V OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4A6V FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.46&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CO3:CARBONATE+ION'>CO3</scene>, <scene name='pdbligand=IKY:N-HYDROXY-2-[2-(TRIFLUOROMETHYL)PHENYL]-1,3-OXAZOLE-4-CARBOXAMIDE'>IKY</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4a6v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4a6v OCA], [https://pdbe.org/4a6v PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4a6v RCSB], [https://www.ebi.ac.uk/pdbsum/4a6v PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4a6v ProSAT]</span></td></tr>
 +
</table>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
New series of acids and hydroxamic acids linked to five-membered heterocycles including furan, oxazole, 1,2,4- or 1,3,4-oxadiazole, and imidazole were synthesized and tested as inhibitors against the Fe(II) , Co(II) , and Mn(II) forms of E. coli methionine aminopeptidase (MetAP) and as antibacterial agents against wild-type and acrAB E. coli strains. 2-Aryloxazol-4-ylcarboxylic acids appeared as potent and selective inhibitors of the Co(II) MetAP form, with IC(50) values in the micromolar range, whereas 5-aryloxazol-2-ylcarboxylic acid regioisomers and 5-aryl-1,2,4-oxadiazol-3-ylcarboxylic acids were shown to be inefficient against all forms of EcMetAP. Regardless of the heterocycle, all the hydroxamic acids are highly potent inhibitors and are selective for the Mn(II) and Fe(II) forms, with IC(50) values between 1 and 2 muM. One indole hydroxamic acid that we previously reported as a potent inhibitor of E. coli peptide deformylase also demonstrated efficiency against EcMetAP. To gain insight into the positioning of the oxazole heterocycle with reversed substitutions at positions 2 and 5, X-ray crystal structures of EcMetAP-Mn complexed with two such oxazole hydroxamic acids were solved. Irrespective of the [metal]/[apo-MetAP] ratio, the active site consistently contains a dinuclear manganese center, with the hydroxamate as bridging ligand. Asp 97, which adopts a bidentate binding mode to the Mn2 site in the holoenzyme, is twisted in both structures toward the hydroxamate bridging ligand to favor the formation of a strong hydrogen bond. Most of the compounds show weak antibacterial activity against a wild-type E. coli strain. However, increased antibacterial activity was observed mainly for compounds with a 2-substituted phenyl group in the presence of the nonapeptide polymyxin B and phenylalanine-arginine-beta-naphthylamide as permeabilizer and efflux pump blocker, respectively, which boost the intracellular uptake of the inhibitors.
-
Authors: Huguet, F., Melet, A., AlvesdeSousa, R., Lieutaud, A., Chevalier, J., Deschamps, P., Tomas, A., Leulliot, N., Pages, J.M., Artaud, I.
+
Hydroxamic Acids as Potent Inhibitors of Fe(II) and Mn(II) E. coli Methionine Aminopeptidase: Biological Activities and X-ray Structures of Oxazole Hydroxamate-EcMetAP-Mn Complexes.,Huguet F, Melet A, Alves de Sousa R, Lieutaud A, Chevalier J, Maigre L, Deschamps P, Tomas A, Leulliot N, Pages JM, Artaud I ChemMedChem. 2012 Jun;7(6):1020-30. doi: 10.1002/cmdc.201200076. Epub 2012 Apr 4. PMID:22489069<ref>PMID:22489069</ref>
-
Description: X-ray structures of oxazole hydroxamate EcMetAp-Mn complexes
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 4a6v" style="background-color:#fffaf0;"></div>
 +
 
 +
==See Also==
 +
*[[Aminopeptidase 3D structures|Aminopeptidase 3D structures]]
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Large Structures]]
 +
[[Category: AlvesdeSousa R]]
 +
[[Category: Artaud I]]
 +
[[Category: Chevalier J]]
 +
[[Category: Deschamps P]]
 +
[[Category: Huguet F]]
 +
[[Category: Leulliot N]]
 +
[[Category: Lieutaud A]]
 +
[[Category: Melet A]]
 +
[[Category: Pages JM]]
 +
[[Category: Tomas A]]

Current revision

X-ray structures of oxazole hydroxamate EcMetAp-Mn complexes

PDB ID 4a6v

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools